CN105998753A - Medicine for treating diabetes, hypertension, limb weakness and dermatosis - Google Patents
Medicine for treating diabetes, hypertension, limb weakness and dermatosis Download PDFInfo
- Publication number
- CN105998753A CN105998753A CN201610568946.7A CN201610568946A CN105998753A CN 105998753 A CN105998753 A CN 105998753A CN 201610568946 A CN201610568946 A CN 201610568946A CN 105998753 A CN105998753 A CN 105998753A
- Authority
- CN
- China
- Prior art keywords
- weight portion
- medicine
- weight
- hypertension
- diabetes
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 title claims abstract description 124
- 206010012601 diabetes mellitus Diseases 0.000 title claims abstract description 39
- 206010020772 Hypertension Diseases 0.000 title claims abstract description 36
- 229940079593 drug Drugs 0.000 title claims abstract description 30
- 208000017520 skin disease Diseases 0.000 title claims abstract description 14
- 206010048768 Dermatosis Diseases 0.000 title claims abstract description 13
- 208000027905 limb weakness Diseases 0.000 title abstract 5
- 231100000861 limb weakness Toxicity 0.000 title abstract 5
- 235000021419 vinegar Nutrition 0.000 claims abstract description 16
- 239000000052 vinegar Substances 0.000 claims abstract description 16
- 241001251068 Formica fusca Species 0.000 claims abstract description 11
- 239000011230 binding agent Substances 0.000 claims description 21
- 239000000203 mixture Substances 0.000 claims description 19
- 239000007788 liquid Substances 0.000 claims description 18
- 235000015112 vegetable and seed oil Nutrition 0.000 claims description 12
- 239000008158 vegetable oil Substances 0.000 claims description 11
- 241000190633 Cordyceps Species 0.000 claims description 10
- 241000222336 Ganoderma Species 0.000 claims description 10
- 238000000034 method Methods 0.000 claims description 9
- 241000937789 Rhodobryum giganteum Species 0.000 claims description 7
- 238000010298 pulverizing process Methods 0.000 claims description 3
- 230000000694 effects Effects 0.000 abstract description 54
- 238000005516 engineering process Methods 0.000 abstract description 2
- 241000411851 herbal medicine Species 0.000 abstract description 2
- 240000008397 Ganoderma lucidum Species 0.000 abstract 2
- 235000001637 Ganoderma lucidum Nutrition 0.000 abstract 2
- 241001248610 Ophiocordyceps sinensis Species 0.000 abstract 2
- 244000046052 Phaseolus vulgaris Species 0.000 abstract 2
- 235000010627 Phaseolus vulgaris Nutrition 0.000 abstract 2
- 235000019484 Rapeseed oil Nutrition 0.000 abstract 2
- 244000042430 Rhodiola rosea Species 0.000 abstract 2
- 235000003713 Rhodiola rosea Nutrition 0.000 abstract 2
- 239000010495 camellia oil Substances 0.000 abstract 2
- 231100000331 toxic Toxicity 0.000 abstract 1
- 230000002588 toxic effect Effects 0.000 abstract 1
- 210000003414 extremity Anatomy 0.000 description 32
- 210000004369 blood Anatomy 0.000 description 27
- 239000008280 blood Substances 0.000 description 27
- 206010028372 Muscular weakness Diseases 0.000 description 22
- 230000036473 myasthenia Effects 0.000 description 22
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 19
- 230000036772 blood pressure Effects 0.000 description 18
- 201000010099 disease Diseases 0.000 description 17
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 16
- 239000008103 glucose Substances 0.000 description 16
- 230000007812 deficiency Effects 0.000 description 15
- 210000002683 foot Anatomy 0.000 description 13
- 210000003734 kidney Anatomy 0.000 description 13
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 12
- 208000024891 symptom Diseases 0.000 description 10
- 206010008190 Cerebrovascular accident Diseases 0.000 description 9
- 208000006011 Stroke Diseases 0.000 description 9
- 239000010409 thin film Substances 0.000 description 8
- 206010011224 Cough Diseases 0.000 description 6
- 102000004877 Insulin Human genes 0.000 description 6
- 108090001061 Insulin Proteins 0.000 description 6
- 206010003549 asthenia Diseases 0.000 description 6
- 208000006673 asthma Diseases 0.000 description 6
- 230000006378 damage Effects 0.000 description 6
- 208000002173 dizziness Diseases 0.000 description 6
- 229940125396 insulin Drugs 0.000 description 6
- 210000004072 lung Anatomy 0.000 description 6
- 235000021147 sweet food Nutrition 0.000 description 6
- 235000013305 food Nutrition 0.000 description 5
- 230000027939 micturition Effects 0.000 description 5
- 108010061435 Enalapril Proteins 0.000 description 4
- 210000004204 blood vessel Anatomy 0.000 description 4
- 210000004556 brain Anatomy 0.000 description 4
- 208000026106 cerebrovascular disease Diseases 0.000 description 4
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 4
- 230000001684 chronic effect Effects 0.000 description 4
- GBXSMTUPTTWBMN-XIRDDKMYSA-N enalapril Chemical compound C([C@@H](C(=O)OCC)N[C@@H](C)C(=O)N1[C@@H](CCC1)C(O)=O)CC1=CC=CC=C1 GBXSMTUPTTWBMN-XIRDDKMYSA-N 0.000 description 4
- 229960000873 enalapril Drugs 0.000 description 4
- 210000002216 heart Anatomy 0.000 description 4
- 208000001072 type 2 diabetes mellitus Diseases 0.000 description 4
- 206010003210 Arteriosclerosis Diseases 0.000 description 3
- 208000037157 Azotemia Diseases 0.000 description 3
- 206010019280 Heart failures Diseases 0.000 description 3
- 208000031226 Hyperlipidaemia Diseases 0.000 description 3
- 206010028980 Neoplasm Diseases 0.000 description 3
- 208000007443 Neurasthenia Diseases 0.000 description 3
- 230000001154 acute effect Effects 0.000 description 3
- 238000004458 analytical method Methods 0.000 description 3
- 208000011775 arteriosclerosis disease Diseases 0.000 description 3
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 3
- 208000029078 coronary artery disease Diseases 0.000 description 3
- 210000003128 head Anatomy 0.000 description 3
- 208000006454 hepatitis Diseases 0.000 description 3
- 230000036039 immunity Effects 0.000 description 3
- 201000001881 impotence Diseases 0.000 description 3
- 208000015181 infectious disease Diseases 0.000 description 3
- 238000002386 leaching Methods 0.000 description 3
- 210000004185 liver Anatomy 0.000 description 3
- 206010025135 lupus erythematosus Diseases 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 230000002107 myocardial effect Effects 0.000 description 3
- 239000001301 oxygen Substances 0.000 description 3
- 229910052760 oxygen Inorganic materials 0.000 description 3
- 210000000952 spleen Anatomy 0.000 description 3
- 210000002784 stomach Anatomy 0.000 description 3
- 208000011580 syndromic disease Diseases 0.000 description 3
- 238000002560 therapeutic procedure Methods 0.000 description 3
- 208000009852 uremia Diseases 0.000 description 3
- 206010000087 Abdominal pain upper Diseases 0.000 description 2
- 201000004384 Alopecia Diseases 0.000 description 2
- 206010002383 Angina Pectoris Diseases 0.000 description 2
- 206010006187 Breast cancer Diseases 0.000 description 2
- 208000026310 Breast neoplasm Diseases 0.000 description 2
- 206010007247 Carbuncle Diseases 0.000 description 2
- 208000024172 Cardiovascular disease Diseases 0.000 description 2
- 206010008909 Chronic Hepatitis Diseases 0.000 description 2
- 206010010774 Constipation Diseases 0.000 description 2
- 208000010228 Erectile Dysfunction Diseases 0.000 description 2
- 206010019233 Headaches Diseases 0.000 description 2
- 206010019468 Hemiplegia Diseases 0.000 description 2
- 208000032843 Hemorrhage Diseases 0.000 description 2
- 206010024229 Leprosy Diseases 0.000 description 2
- 208000019255 Menstrual disease Diseases 0.000 description 2
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 2
- 208000001647 Renal Insufficiency Diseases 0.000 description 2
- 206010040943 Skin Ulcer Diseases 0.000 description 2
- 206010067197 Tinea manuum Diseases 0.000 description 2
- 208000031975 Yang Deficiency Diseases 0.000 description 2
- 210000001015 abdomen Anatomy 0.000 description 2
- 231100000360 alopecia Toxicity 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 210000001124 body fluid Anatomy 0.000 description 2
- 239000010839 body fluid Substances 0.000 description 2
- 210000000988 bone and bone Anatomy 0.000 description 2
- 201000008275 breast carcinoma Diseases 0.000 description 2
- 206010006451 bronchitis Diseases 0.000 description 2
- 244000309466 calf Species 0.000 description 2
- 210000000038 chest Anatomy 0.000 description 2
- 201000001352 cholecystitis Diseases 0.000 description 2
- 235000012000 cholesterol Nutrition 0.000 description 2
- 238000003745 diagnosis Methods 0.000 description 2
- 230000002526 effect on cardiovascular system Effects 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 239000007789 gas Substances 0.000 description 2
- 231100000869 headache Toxicity 0.000 description 2
- 208000019622 heart disease Diseases 0.000 description 2
- 208000014617 hemorrhoid Diseases 0.000 description 2
- 230000023597 hemostasis Effects 0.000 description 2
- 230000001631 hypertensive effect Effects 0.000 description 2
- 208000015210 hypertensive heart disease Diseases 0.000 description 2
- 201000006370 kidney failure Diseases 0.000 description 2
- 210000000629 knee joint Anatomy 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- 210000003205 muscle Anatomy 0.000 description 2
- 208000010125 myocardial infarction Diseases 0.000 description 2
- 210000004165 myocardium Anatomy 0.000 description 2
- 210000005036 nerve Anatomy 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- 230000001575 pathological effect Effects 0.000 description 2
- 230000007170 pathology Effects 0.000 description 2
- 230000000291 postprandial effect Effects 0.000 description 2
- 201000007094 prostatitis Diseases 0.000 description 2
- 230000000630 rising effect Effects 0.000 description 2
- 210000000582 semen Anatomy 0.000 description 2
- 231100000019 skin ulcer Toxicity 0.000 description 2
- 238000005728 strengthening Methods 0.000 description 2
- 230000035922 thirst Effects 0.000 description 2
- 201000004647 tinea pedis Diseases 0.000 description 2
- 210000001835 viscera Anatomy 0.000 description 2
- 239000011800 void material Substances 0.000 description 2
- 206010063409 Acarodermatitis Diseases 0.000 description 1
- 206010002556 Ankylosing Spondylitis Diseases 0.000 description 1
- 241000272814 Anser sp. Species 0.000 description 1
- 241000244186 Ascaris Species 0.000 description 1
- 208000023275 Autoimmune disease Diseases 0.000 description 1
- 208000008035 Back Pain Diseases 0.000 description 1
- 208000012639 Balance disease Diseases 0.000 description 1
- 206010005913 Body tinea Diseases 0.000 description 1
- 206010006458 Bronchitis chronic Diseases 0.000 description 1
- 206010006895 Cachexia Diseases 0.000 description 1
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical class [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 1
- 208000017897 Carcinoma of esophagus Diseases 0.000 description 1
- 206010065559 Cerebral arteriosclerosis Diseases 0.000 description 1
- 241000282994 Cervidae Species 0.000 description 1
- 208000017667 Chronic Disease Diseases 0.000 description 1
- 206010009900 Colitis ulcerative Diseases 0.000 description 1
- 206010010071 Coma Diseases 0.000 description 1
- 208000035473 Communicable disease Diseases 0.000 description 1
- 201000006306 Cor pulmonale Diseases 0.000 description 1
- 208000002249 Diabetes Complications Diseases 0.000 description 1
- 206010012655 Diabetic complications Diseases 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 206010014080 Ecchymosis Diseases 0.000 description 1
- 206010014561 Emphysema Diseases 0.000 description 1
- 208000008967 Enuresis Diseases 0.000 description 1
- 208000004930 Fatty Liver Diseases 0.000 description 1
- 206010017533 Fungal infection Diseases 0.000 description 1
- 206010018367 Glomerulonephritis chronic Diseases 0.000 description 1
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 1
- 208000034507 Haematemesis Diseases 0.000 description 1
- 206010019708 Hepatic steatosis Diseases 0.000 description 1
- 206010020710 Hyperphagia Diseases 0.000 description 1
- 208000004044 Hypesthesia Diseases 0.000 description 1
- 206010021118 Hypotonia Diseases 0.000 description 1
- 206010061216 Infarction Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 206010022489 Insulin Resistance Diseases 0.000 description 1
- 208000005016 Intestinal Neoplasms Diseases 0.000 description 1
- 206010023126 Jaundice Diseases 0.000 description 1
- 208000019395 Lactation disease Diseases 0.000 description 1
- 206010024419 Libido decreased Diseases 0.000 description 1
- 235000004431 Linum usitatissimum Nutrition 0.000 description 1
- 240000006240 Linum usitatissimum Species 0.000 description 1
- 208000008930 Low Back Pain Diseases 0.000 description 1
- 206010058467 Lung neoplasm malignant Diseases 0.000 description 1
- 208000007466 Male Infertility Diseases 0.000 description 1
- 208000002720 Malnutrition Diseases 0.000 description 1
- 206010027514 Metrorrhagia Diseases 0.000 description 1
- 206010028851 Necrosis Diseases 0.000 description 1
- 244000061176 Nicotiana tabacum Species 0.000 description 1
- 235000002637 Nicotiana tabacum Nutrition 0.000 description 1
- 206010030155 Oesophageal carcinoma Diseases 0.000 description 1
- 208000002193 Pain Diseases 0.000 description 1
- 206010033557 Palpitations Diseases 0.000 description 1
- 206010061902 Pancreatic neoplasm Diseases 0.000 description 1
- 241001494479 Pecora Species 0.000 description 1
- 208000029082 Pelvic Inflammatory Disease Diseases 0.000 description 1
- 206010034464 Periarthritis Diseases 0.000 description 1
- 201000007100 Pharyngitis Diseases 0.000 description 1
- 206010035664 Pneumonia Diseases 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 208000004186 Pulmonary Heart Disease Diseases 0.000 description 1
- 206010067171 Regurgitation Diseases 0.000 description 1
- 206010038372 Renal arteriosclerosis Diseases 0.000 description 1
- 208000025747 Rheumatic disease Diseases 0.000 description 1
- 241000447727 Scabies Species 0.000 description 1
- 208000008765 Sciatica Diseases 0.000 description 1
- 208000034189 Sclerosis Diseases 0.000 description 1
- 206010040007 Sense of oppression Diseases 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 206010041349 Somnolence Diseases 0.000 description 1
- 206010041591 Spinal osteoarthritis Diseases 0.000 description 1
- 208000005718 Stomach Neoplasms Diseases 0.000 description 1
- 208000007271 Substance Withdrawal Syndrome Diseases 0.000 description 1
- 206010042576 Suppressed lactation Diseases 0.000 description 1
- 208000002474 Tinea Diseases 0.000 description 1
- 208000009205 Tinnitus Diseases 0.000 description 1
- 206010044302 Tracheitis Diseases 0.000 description 1
- 206010067584 Type 1 diabetes mellitus Diseases 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 201000006704 Ulcerative Colitis Diseases 0.000 description 1
- 208000003443 Unconsciousness Diseases 0.000 description 1
- 206010047295 Ventricular hypertrophy Diseases 0.000 description 1
- 208000012886 Vertigo Diseases 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 208000031971 Yin Deficiency Diseases 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 206010000496 acne Diseases 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 230000001476 alcoholic effect Effects 0.000 description 1
- 229940069428 antacid Drugs 0.000 description 1
- 239000003159 antacid agent Substances 0.000 description 1
- 230000001458 anti-acid effect Effects 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 206010003119 arrhythmia Diseases 0.000 description 1
- 230000006793 arrhythmia Effects 0.000 description 1
- 230000004872 arterial blood pressure Effects 0.000 description 1
- 210000002565 arteriole Anatomy 0.000 description 1
- 208000004670 arteriolosclerosis Diseases 0.000 description 1
- 210000003719 b-lymphocyte Anatomy 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 210000004958 brain cell Anatomy 0.000 description 1
- 235000015496 breakfast cereal Nutrition 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- 201000009267 bronchiectasis Diseases 0.000 description 1
- 230000001914 calming effect Effects 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 230000002490 cerebral effect Effects 0.000 description 1
- 208000036319 cervical spondylosis Diseases 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 201000001883 cholelithiasis Diseases 0.000 description 1
- 208000007451 chronic bronchitis Diseases 0.000 description 1
- 208000019902 chronic diarrheal disease Diseases 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 208000019425 cirrhosis of liver Diseases 0.000 description 1
- AGVAZMGAQJOSFJ-WZHZPDAFSA-M cobalt(2+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+2].N#[C-].[N-]([C@@H]1[C@H](CC(N)=O)[C@@]2(C)CCC(=O)NC[C@@H](C)OP(O)(=O)O[C@H]3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)\C2=C(C)/C([C@H](C\2(C)C)CCC(N)=O)=N/C/2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O AGVAZMGAQJOSFJ-WZHZPDAFSA-M 0.000 description 1
- 230000001447 compensatory effect Effects 0.000 description 1
- 210000004351 coronary vessel Anatomy 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 230000006735 deficit Effects 0.000 description 1
- 230000001934 delay Effects 0.000 description 1
- 230000000994 depressogenic effect Effects 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 235000013325 dietary fiber Nutrition 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 208000001848 dysentery Diseases 0.000 description 1
- 231100000880 dysequilibrium Toxicity 0.000 description 1
- 239000003792 electrolyte Substances 0.000 description 1
- 208000026500 emaciation Diseases 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 239000002158 endotoxin Substances 0.000 description 1
- 230000003628 erosive effect Effects 0.000 description 1
- 201000005619 esophageal carcinoma Diseases 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 235000013410 fast food Nutrition 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 208000010706 fatty liver disease Diseases 0.000 description 1
- 208000017561 flaccidity Diseases 0.000 description 1
- 235000004426 flaxseed Nutrition 0.000 description 1
- 235000013376 functional food Nutrition 0.000 description 1
- 208000024386 fungal infectious disease Diseases 0.000 description 1
- 208000020694 gallbladder disease Diseases 0.000 description 1
- 210000004211 gastric acid Anatomy 0.000 description 1
- 206010017758 gastric cancer Diseases 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 208000035861 hematochezia Diseases 0.000 description 1
- 208000006750 hematuria Diseases 0.000 description 1
- 230000002440 hepatic effect Effects 0.000 description 1
- 231100000283 hepatitis Toxicity 0.000 description 1
- 230000002443 hepatoprotective effect Effects 0.000 description 1
- 201000001421 hyperglycemia Diseases 0.000 description 1
- 208000034783 hypoesthesia Diseases 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 230000007574 infarction Effects 0.000 description 1
- 230000001524 infective effect Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 201000007772 internal hemorrhoid Diseases 0.000 description 1
- 201000002313 intestinal cancer Diseases 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 208000003243 intestinal obstruction Diseases 0.000 description 1
- 201000005851 intracranial arteriosclerosis Diseases 0.000 description 1
- 210000004153 islets of langerhan Anatomy 0.000 description 1
- 230000000366 juvenile effect Effects 0.000 description 1
- 210000003127 knee Anatomy 0.000 description 1
- 208000032839 leukemia Diseases 0.000 description 1
- 229930013686 lignan Natural products 0.000 description 1
- 150000005692 lignans Chemical class 0.000 description 1
- 235000009408 lignans Nutrition 0.000 description 1
- 208000019423 liver disease Diseases 0.000 description 1
- 201000007227 lymph node tuberculosis Diseases 0.000 description 1
- 208000038015 macular disease Diseases 0.000 description 1
- 206010025482 malaise Diseases 0.000 description 1
- 201000004792 malaria Diseases 0.000 description 1
- 208000015486 malignant pancreatic neoplasm Diseases 0.000 description 1
- 230000001071 malnutrition Effects 0.000 description 1
- 235000000824 malnutrition Nutrition 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 206010027175 memory impairment Diseases 0.000 description 1
- 208000030159 metabolic disease Diseases 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 235000020124 milk-based beverage Nutrition 0.000 description 1
- 230000017074 necrotic cell death Effects 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 231100000862 numbness Toxicity 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 208000015380 nutritional deficiency disease Diseases 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000036284 oxygen consumption Effects 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 231100000915 pathological change Toxicity 0.000 description 1
- 230000036285 pathological change Effects 0.000 description 1
- 239000008188 pellet Substances 0.000 description 1
- 230000000505 pernicious effect Effects 0.000 description 1
- 230000002688 persistence Effects 0.000 description 1
- 239000000575 pesticide Substances 0.000 description 1
- 239000005426 pharmaceutical component Substances 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 206010036067 polydipsia Diseases 0.000 description 1
- 208000022530 polyphagia Diseases 0.000 description 1
- 235000021395 porridge Nutrition 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 206010036596 premature ejaculation Diseases 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 210000001747 pupil Anatomy 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 150000003254 radicals Chemical class 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000000552 rheumatic effect Effects 0.000 description 1
- 206010039073 rheumatoid arthritis Diseases 0.000 description 1
- 239000009286 sanguis draxonis Substances 0.000 description 1
- 208000005687 scabies Diseases 0.000 description 1
- 230000036299 sexual function Effects 0.000 description 1
- 244000005714 skin microbiome Species 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 208000005801 spondylosis Diseases 0.000 description 1
- 231100000240 steatosis hepatitis Toxicity 0.000 description 1
- 201000011549 stomach cancer Diseases 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- 210000004243 sweat Anatomy 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 201000003875 tinea corporis Diseases 0.000 description 1
- 231100000886 tinnitus Toxicity 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 230000001052 transient effect Effects 0.000 description 1
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 210000000689 upper leg Anatomy 0.000 description 1
- 210000004291 uterus Anatomy 0.000 description 1
- 239000002435 venom Substances 0.000 description 1
- 210000001048 venom Anatomy 0.000 description 1
- 231100000611 venom Toxicity 0.000 description 1
- 231100000889 vertigo Toxicity 0.000 description 1
- 239000000304 virulence factor Substances 0.000 description 1
- 230000007923 virulence factor Effects 0.000 description 1
- 210000001260 vocal cord Anatomy 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
- 210000003905 vulva Anatomy 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
- 230000002087 whitening effect Effects 0.000 description 1
- 239000002023 wood Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/32—Bones; Osteocytes; Osteoblasts; Tendons; Tenocytes; Teeth; Odontoblasts; Cartilage; Chondrocytes; Synovial membrane
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/618—Molluscs, e.g. fresh-water molluscs, oysters, clams, squids, octopus, cuttlefish, snails or slugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/63—Arthropods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
- A61K36/074—Ganoderma
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/10—Bryophyta (mosses)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/31—Brassicaceae or Cruciferae (Mustard family), e.g. broccoli, cabbage or kohlrabi
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/41—Crassulaceae (Stonecrop family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/46—Eucommiaceae (Eucommia family), e.g. hardy rubber tree
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/55—Linaceae (Flax family), e.g. Linum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/70—Polygonaceae (Buckwheat family), e.g. spineflower or dock
- A61K36/704—Polygonum, e.g. knotweed
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/82—Theaceae (Tea family), e.g. camellia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/898—Orchidaceae (Orchid family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/898—Orchidaceae (Orchid family)
- A61K36/8984—Dendrobium
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/898—Orchidaceae (Orchid family)
- A61K36/8988—Gastrodia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Mycology (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Alternative & Traditional Medicine (AREA)
- Zoology (AREA)
- Developmental Biology & Embryology (AREA)
- Rheumatology (AREA)
- Biomedical Technology (AREA)
- Cell Biology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Immunology (AREA)
- Virology (AREA)
- Gastroenterology & Hepatology (AREA)
- Insects & Arthropods (AREA)
- Marine Sciences & Fisheries (AREA)
- Dermatology (AREA)
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The invention discloses a medicine for treating diabetes, hypertension, limb weakness and dermatosis. The medicine for treating diabetes, hypertension and limb weakness is composed of various medicines of grey beans, cordyceps sinensis, ganoderma lucidum seu japonicum, rhodiola rosea, rhizoma gymnadeniae crassinervidis, ant and the like as well as rapeseed oil; the medicine for treating diabetes, hypertension and limb weakness is composed of various medicines of grey beans, cordyceps sinensis, ganoderma lucidum seu japonicum, rhodiola rosea, rhizoma gymnadeniae crassinervidis, formica fusca and the like as well as camellia oil; the medicine for treating dermatosis and limb weakness is composed of various medicines of cornu cervi degelatinatum, os sepiellae seu sepiae, radix polygoni multiflori, fructus gastrodiae and the like as well as white vinegar. According to the technology provided by the invention, the Chinese herbal medicines, rapeseed oil, camellia oil and white vinegar are immersed so as to obtain the combined medicine. Compared with the existing oral medicine, the external medicine provided by the invention is free of toxic or side effect, simple to prepare, less in patient cost, fast in effect, and time-saving and labor-saving.
Description
Technical field
The present invention relates to one and treat diabetes, hypertension, myasthenia of limbs, dermopathic medicine.
Background technology
Diabetes (diabetes) are by inherited genetic factors, immunologic function disorder, microorganism infection, free radical, essence
The various virulence factors such as god's factor act on body and cause hypoinsulinism, insulin resistant (Insulin
Resistance, IR) etc. and a series of metabolism disorders such as the sugar, protein, fat, water and the electrolyte that cause are combined
Simulator sickness, clinically with hyperglycemia as main feature, model case may occur in which polyuria, polydipsia, polyphagia, becomes thin
Deng performance, i.e. " three-many-one-little " symptom.
Wang Yie (Changchun Traditional Chinese Medical College journal .1996；3:3-4) research finds, quenches one's thirst and also has because of innate deficiency of YANG in the body,
Have the deficiency of vital energy or yang deficiency person from the beginning of the most simultaneously concurrently, and think that card upper dry thirsty, lower frequent micturition now is that fire declines can not
Caused by rising aqueous vapor.Tension and relaxation (Jilin Chinese medicine .1998；5:8-9) to 35 example diabetics etiological analysis
Middle discovery, not only has the ferritic deficiency of YIN, also sees have innate deficiency of YANG in the body, ferritic deficiency of both YIN and YANG person.Wherein the ferritic deficiency of YIN,
Ferritic deficiency of both YIN and YANG person is more common in type 1 diabetes, and innate deficiency of YANG in the body person is more common in type 2 diabetes mellitus.Niu Aijun
Deng (Lv Renhe edits. and diabetes tcm diagnosis and treatment is assembled. China Medical Science Press .1999；217) think；
Current clinical diabetes patient, most courses of disease are longer, and pathology loses with kidney yin kidney yang two or even the five internal organs all void persons are
Many, wherein with insufficiency of kidney-YANG for writing, it treats type 2 diabetes mellitus patient 60 example with homemade Testudinis deer Hypolycemic pellet, has
Efficiency reaches 86.6%.Jiang Ying etc. (Lv Renhe edits. and diabetes tcm diagnosis and treatment is assembled. and China Medical Science is published
Society .1999；307) think, this disease of diabetes and the generation of complication, all relevant with yang deficiency.
The real hazardness of hypertension is to damage the vitals such as the heart, brain, kidney, cause apoplexy (apoplexy),
The serious consequences such as myocardial infarction, renal failure (serious meeting causes uremia).The harm of hypertension is such as
Under: one, cerebrovas-cularaccident: cerebrovas-cularaccident is also known as apoplexy, patient's condition is violent, and fatality rate is high, even if not
Extremely, also great majority are disabled, and are one the most violent in acute cerebrovascular disease.Hyperpietic's blood pressure is the highest,
The incidence rate of apoplexy is the highest.Hypertensive patient is with the presence of the pathology of arteriosclerosis, if cerebral arteriosclerosis is to certain
During degree, add the most exciting or excessive excitement, as accident angry, unexpected generation, acutely transport
Moving, make the hurried rising of blood pressure, rupture of blood vessel in brain is hemorrhage, and blood just overflows into circumvascular cerebral tissue, this
Time, patient goes into a coma immediately, inclines and falls in ground, is commonly called as apoplexy.All patients with hypertension Overexertion, indignation,
Under excited inducement, occur dizzy, have a headache, feel sick, the symptom such as numb, weak, strong suspicion
The possibility of apoplexy, now, should be sent to examination in hospital by patient immediately.Two, renal arteriosclerosis and uremia:
Hypertensive patients renal failure accounts for 10%.Hypertension and kidney have the relation of complexity, a side closely
Face, hypertension causes kidney damage；On the other hand kidney damage increases the weight of hypertension.Hypertension and kidney damage
Can influence each other, form vicious cycle.The hypertension of hurried development can cause renal arterioles diffusivity widely
Pathological changes, causes pernicious renal arteriolosclerosis, thus develops rapidly as uremia.Three, hypertensive heart disease:
Arterial pressure persistence raises, and increases heart burden, forms the left heart of compensatory plump.Hyperpietic is the most left
During ventricular hypertrophy, i.e. form hypertensive heart disease.This disease ultimately results in heart failure.Four, coronary heart disease:
Blood pressure can cause the dysequilibrium between myocardial oxygen delivery amount and oxygen demand.Hyperpietic's blood pressure persistently rises
Height, left room afterload strengthens, and cardiac muscle strength increases, and myocardial oxygen consumption increases therewith, merges coronary artery medicated porridge sample
During hardening, coronary flow reserve function reduces, and myocardial oxygen delivery reduces, and angina pectoris, cardiac muscle therefore occurs
Infarction, heart failure etc..Five, long-term hypertension can also result in the damage of eyes, the most blind.
Skin is the organ that human body is maximum, and dermopathic kind is the most various, and the disease that multiple internal organs occur is also
Table can be had on skin carefully existing.Cause dermopathic reason a lot, the dermatosis that such as infective agent causes,
Usually there is certain infectiousness such as leprosy, scabies, mycosis, skin bacteria infection etc., not only affect health and be good for
Health, and raise fear and social discrimination, but it is as raising and the scientific and technological progress of people's living standard,
The infectious disease such as leprosy have been obviously controlled in the whole world.Other cause dermopathic interior extrinsic factor, as
Mechanicalness, physical property, chemical, biological, incretion, immunity etc., the most increasingly by people
Attention.
Myasthenia of limbs refers in the case of normal physiological is clear-headed, and the extremity of appearance are weak and limp, unable, are unable to lift
Spirit.Believe a lot of people all go out item excessively similar symptom, but few people what reason thought better of be
This phenomenon caused.Long-term extremity are weak and limp unable, substantially medical expert's Therapeutic Method to patient: antibiosis
Plain and supplementary potassium, though symptom is quickly alleviated or disappears, but cures the symptoms, not the disease in fact, therefore, it is very easy to etc.
Not busy regarding it.
Myasthenia of limbs belongs to a kind of subhealth state disease, occur the people of myasthenia of limbs symptom the most also can with drowsiness,
The appearance of the symptoms such as dizziness.Cause limply reason to have much clinically, be broadly divided into physiological and
Pathologic both.Expert explains in detail, limply reason: one, physiological reasons: as malnutrition, mistake
Spending tired, depressed these and broadly fall into physiological reasons, mostly the myasthenia of limbs that this kind of reason causes is temporary transient
Property, it is not necessary to being treated by medicine, as long as supplementing the nutrients, taking a good rest, this phenomenon will
Fade away.Two, pathologic reason: when suffering from hepatic disease, diabetes, chronic nephritis, leukemia,
Myasthenia of limbs is that these diseases are common.
Summary of the invention
Present invention aims to the deficiencies in the prior art, it is provided that one treat diabetes, hypertension,
Myasthenia of limbs, dermopathic medicine.
It is an object of the invention to be achieved through the following technical solutions:
1. a treatment diabetes, hypertension, limply medicine for external use, it is characterised in that described medicine leads to
Cross following methods to prepare:
Medicine is soaked 20～30 days with vegetable oil, soaks medicinal liquid out and can obtain treatment；To soak again
Medicine pulverize after cross 100 mesh sieves, then mix with binding agent i.e. treat diabetes, hypertension, extremity without
The medicine of power.
Described medicine consists of the following composition: Gray Root Pakistan 50～100 weight portion, Cordyceps 50～100 weight
Part, Ganoderma 50～100 weight portion, Radix Rhodiolae 50～100 weight portion, Rhizoma Gymnadeniae 50～100 weight portion,
Formica fusca 50～100 weight portion, Herba Dendrobii 50～100 weight portion, Rhodobryum giganteum 50～100 weight portion,
Endoconcha Sepiae 50～100 weight portion, the Cortex Eucommiae 50～100 weight portion, Cornu Cervi Degelatinatum 50～100 weight portion, Herba Cynomorii
50～100 weight portions, Phaeoporus Obliquus 50～100 weight portion, Fructus Gastrodiae 50～100 weight portion, Semen Lini 50～
100 weight portions, Radix Polygoni Multiflori 50～100 weight, vegetable oil 1500～3000 weight portion.
2. a treatment diabetes, hypertension, limply medicine for external use, it is characterised in that described medicine leads to
Cross following methods to prepare:
Medicine is soaked 20～30 days with Oleum Camelliae, soaks medicinal liquid out and can obtain treatment；To soak again
Medicine pulverize after cross 100 mesh sieves, then mix with binding agent i.e. treat diabetes, hypertension, extremity without
The medicine of power.
Described medicine consists of the following composition: Gray Root Pakistan 50～100 weight portion, Cordyceps 50～100 weight
Part, Ganoderma 50～100 weight portion, Radix Rhodiolae 50～100 weight portion, Rhizoma Gymnadeniae 50～100 weight portion,
Formica fusca 50～100 weight portion, Herba Dendrobii 50～100 weight portion, Rhodobryum giganteum 50～100 weight portion,
Endoconcha Sepiae 50～100 weight portion, the Cortex Eucommiae 50～100 weight portion, Cornu Cervi Degelatinatum 50～100 weight portion, Herba Cynomorii
50～100 weight portions, Phaeoporus Obliquus 50～100 weight portion, Fructus Gastrodiae 50～100 weight portion, Semen Lini 50～
100 weight portions, Radix Polygoni Multiflori 50～100 weight, Oleum Camelliae 1500～3000 weight portion.
3. a treatment dermatosis, limply medicine for external use, it is characterised in that described medicine is by with lower section
Method prepares:
Medicine is soaked 20～30 days with white vinegar, soaks medicinal liquid out and can obtain treatment；To soak again
Medicine crosses 100 mesh sieves after pulverizing, and i.e. treats dermatosis, limply medicine as then mixing with binding agent
Thing.
Described medicine consists of the following composition: ground Cordyceps 50～100 weight portion, Radix Polygoni Multiflori 50～100 weight
Part, Ganoderma 50～100 weight portion, Radix Rhodiolae 50～100 weight portion, Rhizoma Gymnadeniae 50～100 weight portion,
Formica fusca 50～100 weight portion, Endoconcha Sepiae 50～100 weight portion, the Cortex Eucommiae 50～100 weight portion, Cornu Cervi
Frost 50～100 weight portions, Herba Cynomorii 50～100 weight portion, Fructus Gastrodiae 50～100 weight portion, white vinegar 1500～
3000 weight portions.
The invention has the beneficial effects as follows: 1 present invention can effectively treat the blood of hypertension, myasthenia of limbs, diabetes
Sugar higher dizziness, and patient have in hospital can not, patient can use doctor's prescription oral medicine or islets of langerhans
Element, then add the medicine for external use of the present invention, tentatively use about one week blood glucose to return to substantially normally through patient, or give
Anti-sclerosis of blood vessels.2, the present invention effectively treats myasthenia of limbs, dermatosis and the specific drug of tinea manus and pedis patient, has
Benefiting: comedo, numb hand and foot, sheep is insane crazy.The medicine for external use of the present invention compared with existing oral medicine, when
The medicine no side effects of the front present invention.
The multiple diseases such as diabetes, hypertension, myasthenia of limbs treated on the basis of original by the medicine of the present invention,
Chinese herb medicine and vegetable oil (or select Oleum Camelliae, white vinegar all can) be soaked by inventor, and result medicine serves thing
Rational role, has played unprecedented beyond thought effect to human body, and the medicinal liquid soaked is entered by inventor
The tuerculoderma of pedestrian's body, has obtained diabetes, hypertension, myasthenia of limbs, numb hand and foot, tinea manus and pedis,
Treating for skin disease effect.So, solve the demand that existing oral medicine is unsatisfactory for patient.
Therefore, inventor is weak and limp to patient's extremity, unable, the analysis of numb hand and foot: extremity are weak and limp unable is
A kind of macular disease, and Other diseases can be caused, it should treat with medicine for external use for main body, it is to avoid
The misery unnecessary to patient and loss.Applicant wants that inventing a kind of medicine for external use fills up the blank of this treatment, solves
Certainly existing medicine is insufficient for the problem of patient demand, contributes for the mankind！
Detailed description of the invention
Effect of major pharmaceutical component and effect:
1, effect of Gray Root Pakistan and effect: Gray Root Pakistan has replenishing QI to invigorate the spleen, nourishing kidney yin, antiinflammatory, alleviation
Diabetic symptom, improve that B cell is not enough, promote the balance of nature of internal blood glucose, Yin Yang balancing,
QI and blood regulating, correct effect that generation is disorderly, prevent diabetic complication, be mainly used to treat type ii diabetes,
Be described as be folk therapy diabetes excellent folk prescription, fall the diabetes test of pesticide effectiveness notable.
2, effect of Cordyceps and effect: lung heat clearing of inducing sweat；Eliminating damp, detoxifying；Qi-restoratives spleen invigorating anemopyretic cold；Empty
Impairment and cough；Jaundice；Stranguria；Sore swells and ache；Venom.
3, effect of Ganoderma and effect: treatment cardiovascular disease, hyperlipidemia, arteriosclerosis, coronary heart disease, covet
Blood, neurasthenia, asthma, tracheitis, prostatitis, urgent micturition frequent micturition, hepatocarcinoma, esophageal carcinoma, cancer of pancreas,
Osteocarcinoma, breast carcinoma, pulmonary carcinoma, acute and chronic hepatocarcinoma, early stage liver cirrhosis, rheumatism, digestive tract burst intestinal, lung knot
Core etc..
4, effect of Radix Rhodiolae and effect: benefiting QI for activating blood circulation, promote blood circulation and relieving asthma；Cure mainly empty blood stasis, obstruction of qi in the chest and cardialgia,
Apoplectic hemiplegia, asthenia asthma etc..
5, effect of Rhizoma Gymnadeniae and effect: there is effect of benefiting vital QI and blood, promoting the production of body fluid to quench thirst, control cough and asthma due to lung deficiency,
The symptoms such as asthenia is become thin, neurasthenia, and chronic diarrhea is lost blood, leukorrhagia, and breast is few, chronic hepatitis.
6, effect of Formica fusca and effect: 1., rheumatic ostalgia crowd, anti-dispelling the wind and dampness pathogens, rheumatoid arthritis,
Scapulohumeral periarthritis, ankylosing spondylitis, hemiplegia, cervical spondylosis, sciatica, osteodynia, head necrosis；②、
Hepatoprotective, prevents and treats B-mode liver, fatty liver, alcoholic liver, cholecystitis etc.；3., relieving cough and asthma, prevent and treat asthma, cough
Cough, acute/chronic bronchitis, bronchiectasis, chronic pharyngitis, emphysema, pulmonary heart disease, consumptive disease are hindered, one hundred days
Lung, the temper deficient syndrome such as cough；4., kidney-tonifying health-care, YIN nourishing and YANG strengthening, replenishing essence solid marrow, sexual function improving, prevent and treat sexual impotence,
Seminal emission, prostatitis, woman's hyposexuality, menoxenia, cold uterus, puerperal exposure to wind, puerperal hypogalactia；5., all
The weighing apparatus flat body of nutrition, two-ways regulation immunity, cancer-resisting, slow down aging；6., adjust blood pressure, vessel softening,
Preventing and treating cardiovascular and cerebrovascular disease, coronary heart disease, diabetes, hypertension, hyperlipidemia, hyperlipidemia, arteriosclerosis, the heart
Angor, myocardial infarction, heart failure, numbness of hands and feet, apoplexy omen, feeling of oppression and pain in the chest, arrhythmia etc.；⑦、
Invigorating qi and benefiting blood improve endurance resisting fatigue, improve palpitation and short breath, have a dizzy spell, tinnitus, faint, emaciation and sallow complexion,
Myasthenia of limbs etc.；8., hemorrhoid, constipation；9., lupus erythematosus, post disease alopecia, teen-ager leukotrichia.
7, effect of Herba Dendrobii and effect: Herba Dendrobii have nourishing YIN and moistening the lung, nourishing the stomach to promote the production of body fluid, brain-strengthening item,
Mend magical effect of the asthenia of five lungs, to increase immunity, defying age, anti-curing cancers, treatment diabetes and
Atrophic pneumonia has a definite curative effect, excessive to tobacco and wine, overwork, night life excessively, by ophthalmically acceptable brain mistake
The recoveries such as degree, vocal cords are hoarse have special efficacy.Treat the medicine dedicated of diabetes the most exactly.Clinic is ground
Studying carefully and show, Herba Dendrobii is possible not only to strengthen insulin active, can significantly reduce blood sugar level simultaneously, make blood
Normally；Circulation, expansion blood vessel can be promoted, reduce cholesterolemia and triglyceride.It is to treat various liver-gallbladder disease
Key medicine, can be used for treating the liver and gall diseases such as hepatitis, cholecystitis, cholelithiasis.Mainly originate from Zhejiang, Fujian
One band, once there was a few phase program in the Chinese Central Television (CCTV), says rare Chinese medicine specially, it should be particularly mentioned Herba Dendrobii,
The wild place of production is mainly in Wild Goose and Reed Marsh Mountains.
8, effect of Rhodobryum giganteum and effect: calmness of calming the nerves, treatment heart disease is nervous, cardiopalmus, neurasthenia etc.
Symptom.
9, effect of Endoconcha Sepiae and effect: be the one effect with dehumidifying, antacid, hemostasis, sword；Stomachache
Acid regurgitation, tell, be defeated in battle, hematemesis, stomachache of having blood in stool lump in the abdomen, the rotten skin ulcer of the erosion of the vulva etc..
10, effect of the Cortex Eucommiae and effect: treatment deficiency of the kidney void, vertigo, waist knee joint muscles and bones flaccidity kidney weak, chronic
Disease, chronic pelvic inflammatory disease disease.
11, effect of Cornu Cervi Degelatinatum and effect: be that one has warming the kidney to activate YANG, receives effect of sword hemostasis；Spleen kidney
Sexual impotence, lack of appetite and vomiting, leucorrhea, enuresis frequent micturition, metrostaxis, carbuncle sucutaneous nodule etc..
12, effect of Herba Cynomorii and effect: clinic Herba Cynomorii cures mainly impotence and premature ejaculation, the moon declines Sanguis Draxonis；The weak deficiency of YIN of gas,
Constipation due to dry stool, frequent micturition, hematuria, dripping not to the utmost；Soreness of the waist and knees, fatigue and weak；Fear of cold is the coldest, and extremity ache
Bitterly；Menoxenia, cold womb leukorrhagia；Infertilitas feminis, male infertility；Insomnia forgetfulness, alopecia is the whitest, gastric acid ulcer etc.
Deng.
13, effect of Phaeoporus Obliquus and effect: for various difficult miscellaneous diseases, gastric cancer, hepatocarcinoma, intestinal cancer, various
Disappear disease, heart disease, diabetes, blood pressure lowering, blood fat reducing, and have eliminating enterogenous endotoxin, improve looks, lose weight
Etc. effect.
14, effect of Fructus Gastrodiae and effect: the headache of qi-restoratives subduing the wind syndrome, dizziness, pupil, wind syndrome of head, few gas consumption of essence,
Early whitening of beard and hair etc..
15, effect of Semen Lini and effect: there is the effect of lowering blood pressure and blood fat, containing more wooden phenol
Element, can effectively prevent the growth of diabetes and tumor, and EPA, DHA in Semen Lini contribute to brain cell
Formation, g and D, to improving juvenile intelligence, protecting vision to play an important role.
In recent years, based on Canada, Australia, Britain and the western developed country of the U.S., to Caulis et Folium Lini
Seed has made substantial amounts of work, with linseed meal as generation as research and the exploitation of Ao Kendi Semen Lini of functional food
The product of table appears on the market for many years already, in becoming, the standing health product of old people.Recently, meet health giving quality to want
High-purity, the product of standardization lignan extract asked also list, can be widely applied to capsule, tabletting,
Breakfast cereal and the additive of fast food.Also have containing omega-fatty acid, soluble dietary fiber and wood phenol
The multiple products such as the super dense emulsion of nutrient functional of element and full milk beverage constantly occur commercially.Semen Lini
There is anticancer and breast carcinoma, improve function of suffering from a deficiency of the kidney, the autoimmune disease of similar lupus for the treatment of etc, with
And the problem that the inflammatory reaction such as ulcerative colitis causes.
16, effect of Radix Polygoni Multiflori and effect: treatment hepatic and renal YIN deficiency, send out must the whitest, blood deficiency is dizzy, waist knee joint is soft
Weak, muscles and bones is ached, is passed out semen, metrorrhagia and leukorrhagia, chronic malaria, chronic dysentery, chronic hepatitis, carbuncle, scrofula, hemorrhoidal hamorrhage, hemorrhoid
The disease such as skin ulcer, lupus hung classes.
17, effect of Oleum Brassicae campestris and effect: and have certain softening blood, delays sorrow old, to blood vessel, nerve,
The growth of brain is particularly significant.The cholesterol of Oleum Brassicae campestris is with little or no containing, and " food book on Chinese herbal medicine " also calls vegetable oil
" applying head, order black send out long.The stagnant blood of row；Broken cold air, dispersing swelling and dissipating binds.Managing property difficulty, puerperal, trusted subordinate Zhu Ji, red
Red heat is swollen, incised wound internal hemorrhoid with bleeding ".Being clinically used for ascaris and food intestinal obstruction, effect is preferable.
18, effect of Oleum Camelliae and effect: Oleum Camelliae has more than 2300 year history so far in China, the kindest
Auspiciousness too Hou and precious prince wife prefer to use Oleum Camelliae to nurse skin.Soong Mayling the most just before going to bed, must be named and provide special care to use mountain by example
Tea flower seed oil gives her face and whole body massage one time, and skin is ruddy.Edible to diseases such as hypertension, cardiovascular and cerebrovascular vessel
Play great role.
19, effect of white vinegar and effect: white vinegar the person is had the biggest good outside, since ancient times, be the mankind
The food left, single from white vinegar analysis；The diseases such as white vinegar external can control lumbago and skelalgia, and ash refers to (toe) first, tinea corporis,
White vinegar soaks Semen arachidis hypogaeae and eats, and can reduce blood pressure and the effect of cholesterol.
Present invention aims to the deficiencies in the prior art, it is provided that one treat diabetes, hypertension,
Myasthenia of limbs, dermopathic medicine.
It is an object of the invention to be achieved through the following technical solutions:
1. one kind treat diabetes, hypertension, extremity without medicine for external use, it is characterised in that described medicine passes through
Following methods prepares:
Medicine is soaked 20～30 days with vegetable oil, soaks medicinal liquid out and can obtain treatment；To soak again
Medicine pulverize after cross 100 mesh sieves, then mix with binding agent i.e. treat diabetes, hypertension, extremity without
The medicine of power.
Described medicine consists of the following composition: Gray Root Pakistan 50～100 weight portion, Cordyceps 50～100 weight
Part, Ganoderma 50～100 weight portion, Radix Rhodiolae 50～100 weight portion, Rhizoma Gymnadeniae 50～100 weight portion,
Formica fusca 50～100 weight portion, Herba Dendrobii 50～100 weight portion, Rhodobryum giganteum 50～100 weight portion,
Endoconcha Sepiae 50～100 weight portion, the Cortex Eucommiae 50～100 weight portion, Cornu Cervi Degelatinatum 50～100 weight portion, Herba Cynomorii
50～100 weight portions, Phaeoporus Obliquus 50～100 weight portion, Fructus Gastrodiae 50～100 weight portion, Semen Lini 50～
100 weight portions, Radix Polygoni Multiflori 50～100 weight, vegetable oil 1500～3000 weight portion.
2. a treatment diabetes, hypertension, limply medicine for external use, it is characterised in that described medicine leads to
Cross following methods to prepare:
Medicine is soaked 20～30 days with Oleum Camelliae, soaks medicinal liquid out and can obtain treatment；To soak again
Medicine pulverize after cross 100 mesh sieves, then mix with binding agent i.e. treat diabetes, hypertension, extremity without
The medicine of power.
Described medicine consists of the following composition: Gray Root Pakistan 50～100 weight portion, Cordyceps 50～100 weight
Part, Ganoderma 50～100 weight portion, Radix Rhodiolae 50～100 weight portion, Rhizoma Gymnadeniae 50～100 weight portion,
Formica fusca 50～100 weight portion, Herba Dendrobii 50～100 weight portion, Rhodobryum giganteum 50～100 weight portion,
Endoconcha Sepiae 50～100 weight portion, the Cortex Eucommiae 50～100 weight portion, Cornu Cervi Degelatinatum 50～100 weight portion, Herba Cynomorii
50～100 weight portions, Phaeoporus Obliquus 50～100 weight portion, Fructus Gastrodiae 50～100 weight portion, Semen Lini 50～
100 weight portions, Radix Polygoni Multiflori 50～100 weight, Oleum Camelliae 1500～3000 weight portion.
3. a treatment dermatosis, limply medicine for external use, it is characterised in that described medicine is by with lower section
Method prepares:
Medicine is soaked 20～30 days with white vinegar, soaks medicinal liquid out and can obtain treatment；To soak again
Medicine crosses 100 mesh sieves after pulverizing, and i.e. treats dermatosis, limply medicine as then mixing with binding agent
Thing.
Described medicine consists of the following composition: ground Cordyceps 50～100 weight portion, Radix Polygoni Multiflori 50～100 weight
Part, Ganoderma 50～100 weight portion, Radix Rhodiolae 50～100 weight portion, Rhizoma Gymnadeniae 50～100 weight portion,
Formica fusca 50～100 weight portion, Endoconcha Sepiae 50～100 weight portion, the Cortex Eucommiae 50～100 weight portion, Cornu Cervi
Frost 50～100 weight portions, Herba Cynomorii 50～100 weight portion, Fructus Gastrodiae 50～100 weight portion, white vinegar 1500～
3000 weight portions.
Below in conjunction with embodiment, the invention will be further described:
Embodiment one: the treatment of diabetics；
Mix homogeneously with vegetable oil according to described medicine for external use, soak medicinal liquid with gauze and be bonded at position bottom both feet, then outside
Protect with thin film.During treating certain diabetics with this, patient is administered orally doctor to his prescription the most simultaneously
Medicine, does not drinks, do not eat sweet food product other as before.
Through 9 initial stage fasting glucose between 17-20, the binding agent external used medicine of patient's trial edition embodiment
Second day, fasting glucose drops between 13-16, and post-prandial glycemia reduces equally, and within about one week, blood glucose is reduced to
Normal range.I.e. subtracting oral medicine or insulin half, second day blood glucose can raise 2～at about 3, the 3rd day
Fasting glucose progressively declines, and within three to six days, blood glucose drops to normal range, and about about 15～20 days by all of mouth
Take medicine and insulin stops, using binding agent medicine for external use to keep blood glucose normal.Patient uses this medicine one month
In sole skin is not affected.7 patients of successful treatment.
Embodiment two: the treatment of hyperpietic；
Mix homogeneously with vegetable oil according to described medicine for external use, soak medicinal liquid with gauze and be bonded at position bottom both feet, then outside
Protect with thin film.During treating certain hyperpietic with this, patient is administered orally doctor to his prescription the most simultaneously
Medicine, does not drinks, do not eat sweet food product other as before.
Through 2 initial stage hyperpietic's high pressure between 160～190, between low pressure 110～120, suffer from
With second day of the binding agent external used medicine of the present embodiment at the beginning of person, high pressure is down between 150-170, and low pressure is down to
Between 100～110, within about 7～8 days, blood pressure returns to substantially normal range.I.e. subtract enalapril meleate half, the
Within two days, blood pressure can raise a bit, and within the 3rd day, empty stomach blood pressure progressively declines, and within three to five days, blood pressure drops to normal range,
All of enalapril meleate was stopped in about about 15 days, use binding agent medicine for external use to keep blood pressure normal.Patient
Use this medicine in one month sole skin be not affected.2 patients of successful treatment.
Embodiment three: the treatment of myasthenia of limbs patient；
Mix homogeneously with vegetable oil according to described medicine for external use, with gauze leaching medicinal liquid and be bonded at both feet the end, calf and
The positions such as arm, then the protection of external thin film.During treating certain myasthenia of limbs patient with this, patient does not drinks,
Do not eat sweet food product other as before.
Through 3 myasthenia of limbs, patient tentatively uses the binding agent external used medicine of the present embodiment to stop after 5-7 days
Medication, not recurrence in a year, successfully cure 3 patients.
Embodiment four: diabetic therapy:
Mix homogeneously with Oleum Camelliae according to described medicine for external use, soak medicinal liquid with gauze and be bonded at position bottom both feet, then outside
Protect with thin film.During treating certain diabetics with this, patient is administered orally doctor to his prescription the most simultaneously
Medicine, does not drinks, do not eat sweet food product other as before.
The binding agent external used medicine of 3 initial stage fasting glucose patient's trial edition embodiment between 17-20
Second day, fasting glucose dropped between 13-16, and post-prandial glycemia reduces equally, and within about one week, blood glucose is just reduced to
Often scope.I.e. subtracting oral medicine or insulin half, second day blood glucose can raise 2～at about 3, the 3rd sky
Abdomen blood glucose progressively declines, and within three to six days, blood glucose drops to normal range, and about about 15～20 days by all of oral
Medicine and insulin stop, and only use binding agent medicine for external use to keep blood glucose normal.Use this medicine foot in month
End skin is not affected.3 patients of successful treatment.
Embodiment five: the treatment of hyperpietic；
According to described, medicine for external use is mixed homogeneously with Oleum Camelliae, soak medicinal liquid with gauze and be bonded at position bottom both feet, then
External thin film is protected.During treating certain hyperpietic with this, patient is administered orally the place that doctor opens to him the most simultaneously
Side medicine, do not drink, do not eat sweet food product other as before.
5 high pressure hyperpietic's trial edition medicine between 160～180, between low pressure 110～120,
With second day of the binding agent external used medicine of the present embodiment at the beginning of patient, high pressure is down between 150～165, low pressure
Being down between 100～105, within about 7～8 days, blood pressure returns to substantially normal range.I.e. subtract enalapril meleate half,
Within second day, blood pressure can raise a bit, and within the 3rd day, empty stomach blood pressure progressively declines, and within three to five days, blood pressure drops to normal model
Enclose, all of enalapril meleate was stopped in about about 15 days, only use binding agent medicine for external use to keep blood pressure normal.
Use this medicine in one month sole skin be not affected.5 patients of successful treatment.
Embodiment six: the treatment of myasthenia of limbs patient；
According to described, medicine for external use is mixed homogeneously with Oleum Camelliae, soak medicinal liquid with gauze and be bonded at the both feet end, calf
And the position such as arm, then external thin film protection.During treating certain myasthenia of limbs patient with this, patient does not drinks,
Do not eat sweet food product other as before.
Through 3 myasthenia of limbs, patient tentatively uses the binding agent external used medicine of the present embodiment to stop after 5-7 days
Medication, not recurrence in half a year, successfully cure 3 patients.
Embodiment seven: the treatment of dermatosis patient:
According to described, medicine for external use is mixed homogeneously with white vinegar, with gauze leaching medicinal liquid and be bonded at skin affected part position,
External thin film protection again.Using about three to four days, the position that skin is suffered from can play blood red point naturally, does not suffer from
Dermopathic position skin does not haves ecchymosis, illustrates very successful, suffers from the thin mattress in dermopathic position and substantially kills,
Must not drug withdrawal, continue with three to four days.Patient does not drinks, and other food is as before.
Through 18 dermatosis patients, patient tentatively uses the binding agent external used medicine of the present embodiment to stop for 6-7 days
Only medicine, not recurrence in 5 years, 16 patients successfully cure.
Embodiment eight: the treatment of myasthenia of limbs patient:
According to described, medicine for external use is mixed homogeneously with white vinegar, with gauze leaching medicinal liquid and be bonded at both feet the end, shank and
Thigh, arm, the position such as back, then the protection of external thin film.Patient does not drinks, and other food is as before.
Tentatively use the binding agent external used medicine of the present embodiment through 8 myasthenia of limbs patients, stop after 5-7 days
Only medication, not recurrence in two year, successfully cure 8 patients.
Claims (3)
1. a treatment diabetes, hypertension, limply medicine for external use, it is characterised in that described medicine
It is prepared by the following method and obtains:
Medicine is soaked 20～30 days with vegetable oil, soaks medicinal liquid out and can obtain treatment；To soak again
Medicine pulverize after cross 100 mesh sieves, then mix with binding agent i.e. treat diabetes, hypertension, extremity without
The medicine of power.
Described medicine consists of the following composition: Gray Root Pakistan 50～100 weight portion, Cordyceps 50～100 weight
Part, Ganoderma 50～100 weight portion, Radix Rhodiolae 50～100 weight portion, Rhizoma Gymnadeniae 50～100 weight portion,
Formica fusca 50～100 weight portion, Herba Dendrobii 50～100 weight portion, Rhodobryum giganteum 50～100 weight portion,
Endoconcha Sepiae 50～100 weight portion, the Cortex Eucommiae 50～100 weight portion, Cornu Cervi Degelatinatum 50～100 weight portion, Herba Cynomorii
50～100 weight portions, Phaeoporus Obliquus 50～100 weight portion, Fructus Gastrodiae 50～100 weight portion, Semen Lini 50～
100 weight portions, Radix Polygoni Multiflori 50～100 weight, vegetable oil 1500～3000 weight portion.
2. a treatment diabetes, hypertension, limply medicine for external use, it is characterised in that described medicine leads to
Cross following methods to prepare:
Medicine is soaked 20～30 days with Oleum Camelliae, soaks medicinal liquid out and can obtain treatment；To soak again
Medicine pulverize after cross 100 mesh sieves, then mix with binding agent i.e. treat diabetes, hypertension, extremity without
The medicine of power.
Described medicine consists of the following composition: Gray Root Pakistan 50～100 weight portion, Cordyceps 50～100 weight
Part, Ganoderma 50～100 weight portion, Radix Rhodiolae 50～100 weight portion, Rhizoma Gymnadeniae 50～100 weight portion,
Formica fusca 50～100 weight portion, Herba Dendrobii 50～100 weight portion, Rhodobryum giganteum 50～100 weight portion,
Endoconcha Sepiae 50～100 weight portion, the Cortex Eucommiae 50～100 weight portion, Cornu Cervi Degelatinatum 50～100 weight portion, Herba Cynomorii
50～100 weight portions, Phaeoporus Obliquus 50～100 weight portion, Fructus Gastrodiae 50～100 weight portion, Semen Lini 50～
100 weight portions, Radix Polygoni Multiflori 50～100 weight, Oleum Camelliae 1500～3000 weight portion.
3. a treatment dermatosis, limply medicine for external use, it is characterised in that described medicine is by with lower section
Method prepares:
Medicine is soaked 20～30 days with white vinegar, soaks medicinal liquid out and can obtain treatment；To soak again
Medicine crosses 100 mesh sieves after pulverizing, and i.e. treats dermatosis, limply medicine as then mixing with binding agent
Thing.
Described medicine consists of the following composition: ground Cordyceps 50～100 weight portion, Radix Polygoni Multiflori 50～100 weight
Part, Ganoderma 50～100 weight portion, Radix Rhodiolae 50～100 weight portion, Rhizoma Gymnadeniae 50～100 weight portion,
Formica fusca 50～100 weight portion, Endoconcha Sepiae 50～100 weight portion, the Cortex Eucommiae 50～100 weight portion, Cornu Cervi
Frost 50～100 weight portions, Herba Cynomorii 50～100 weight portion, Fructus Gastrodiae 50～100 weight portion, white vinegar 1500～
3000 weight portions.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201610568946.7A CN105998753A (en) | 2016-07-13 | 2016-07-13 | Medicine for treating diabetes, hypertension, limb weakness and dermatosis |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201610568946.7A CN105998753A (en) | 2016-07-13 | 2016-07-13 | Medicine for treating diabetes, hypertension, limb weakness and dermatosis |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN105998753A true CN105998753A (en) | 2016-10-12 |
Family
ID=57115772
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201610568946.7A Pending CN105998753A (en) | 2016-07-13 | 2016-07-13 | Medicine for treating diabetes, hypertension, limb weakness and dermatosis |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN105998753A (en) |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1269402A (en) * | 1999-04-01 | 2000-10-11 | 宋栋梁 | Chiense herbal medicine wine |
| CN101564431A (en) * | 2009-06-15 | 2009-10-28 | 伍俊杰 | Chinese medicament preparation for keeping fit, resisting fatigue and fighting senium and producing method thereof |
| CN103977253A (en) * | 2014-05-22 | 2014-08-13 | 卢祥平 | Drug for external use for treating diabetes mellitus |
-
2016
- 2016-07-13 CN CN201610568946.7A patent/CN105998753A/en active Pending
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1269402A (en) * | 1999-04-01 | 2000-10-11 | 宋栋梁 | Chiense herbal medicine wine |
| CN101564431A (en) * | 2009-06-15 | 2009-10-28 | 伍俊杰 | Chinese medicament preparation for keeping fit, resisting fatigue and fighting senium and producing method thereof |
| CN103977253A (en) * | 2014-05-22 | 2014-08-13 | 卢祥平 | Drug for external use for treating diabetes mellitus |
Non-Patent Citations (2)
| Title |
|---|
| 张英: "《膳食营养保健功能手册》", 31 March 2012, 中国纺织出版社 * |
| 王启才等: "《王启才新针灸学》", 31 July 2008, 中医古籍出版社 * |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102048933B (en) | Chinese medicinal composition for treating infantile diarrhea and preparation method thereof | |
| CN103405728B (en) | A kind of Chinese medicine composition for the treatment of climacteric syndrome and preparation method thereof | |
| CN108277138A (en) | A kind of health-care and nutritious wine and preparation method thereof | |
| CN103211930A (en) | Traditional Chinese preparation for reducing blood fat and blood pressure | |
| CN107596197A (en) | A kind of strongly fragrant tea of tonifying Qi solution and preparation method thereof | |
| CN104225532B (en) | Treat the jianpiwenshen pills of ankylosing spondylitis | |
| CN104225200A (en) | Traditional Chinese medicine for treating fluid retention invading heart-lung type cardiac asthma and preparation method thereof | |
| CN107890521A (en) | A kind of Chinese medicine composition of liver protection and eyesight and its preparation method of pill | |
| CN102988747B (en) | Aristida triseta electuary for reducing hypertension, hyperglycemia and hyperlipidemia and preparation method thereof | |
| CN103861075B (en) | Chinese medicine being used for the treatment of insomnia and preparation method thereof | |
| CN103223137B (en) | Traditional Chinese medicinal preparation for reducing blood sugar | |
| CN103202964B (en) | Brain-improving and mind-calming medicinal liquor | |
| CN105435190A (en) | Traditional Chinese medicine composition for treating cold-heat jumble asthma and preparation method of traditional Chinese medicine composition | |
| CN104906394A (en) | Traditional Chinese medicine for treating liver and kidney yin deficiency and qi and blood deficiency type hypertension | |
| CN104522493A (en) | Health porridge for treating coronary atherosclerosis and preparation method of health porridge | |
| CN105998753A (en) | Medicine for treating diabetes, hypertension, limb weakness and dermatosis | |
| CN104474235A (en) | Health traditional Chinese medicine wine for tonifying spleen and harmonizing stomach and preparation method of traditional Chinese medicine wine | |
| CN108524861A (en) | A kind of traditional Chinese medicinal ointment and preparation method thereof for treating insomnia | |
| CN102600271A (en) | Chinese medicinal preparation for treating nervous headache | |
| CN106822852A (en) | Treat pharmaceutical composition, its preparation technology and the purposes of coronary heart disease | |
| CN106668556A (en) | Dendrobium candidum health-care wine and preparation method thereof | |
| CN103356984B (en) | Traditional Chinese medicine composition for preventing and treating female iron deficiency anemia | |
| CN105267815A (en) | Spray for treating infant lung-kidney-deficiency type asthma and preparing method thereof | |
| CN105012732A (en) | Traditional Chinese medicine pill for treating sleep disorder syndrome and preparation method thereof | |
| CN104840872A (en) | Traditional Chinese medicine for treating stable angina pectoris of coronary heart disease complicated with diabetic hyperlipemia |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20161012 |